Mercado europeo de bronquiectasias: tendencias de la industria y pronóstico hasta 2028

Personalice su informePersonalice su informe Compre ahoraCompre ahora Ejemplo de informe gratuitoEjemplo de informe gratuito
Hogar Pharmaceutical Europe Bronchiectasis Market
Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Mercado europeo de bronquiectasias: tendencias de la industria y pronóstico hasta 2028

  • Pharmaceutical
  • Published Report
  • Mar 2021
  • Europe
  • 350 Páginas
  • Número de tablas: 440
  • Número de figuras: 56
Comprar ahoraComprar ahora

Mercado europeo de bronquiectasias, por tipo de enfermedad (bronquiectasias por fibrosis quística y bronquiectasias sin fibrosis quística), gravedad (leve a moderada y moderada a grave), tipo (diagnóstico y tratamiento), tipo de medicamento (de marca y genéricos), vía de administración (oral, parenteral e inhalación), usuario final (hospitales, clínicas, atención médica domiciliaria y otros), canal de distribución (farmacia hospitalaria, farmacia minorista, farmacia en línea, otros), país (Alemania, Reino Unido, Francia, Italia, España, Países Bajos, Rusia, Suiza, Bélgica, Turquía, Austria, Noruega, Hungría, Lituania, Irlanda, Polonia, resto de Europa), tendencias de la industria y pronóstico hasta 2028

Mercado europeo de la bronquiectasiaAnálisis y perspectivas del mercado: mercado europeo de la bronquiectasia

Se espera que el mercado de bronquiectasias gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 5,6% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 250,46 millones para 2028. El creciente número de consumidores de alcohol y fumadores y el avance tecnológico para las pruebas de enfermedades son los principales impulsores que impulsaron la demanda del mercado de bronquiectasias en el período de pronóstico.

La bronquiectasia es un término derivado de la palabra griega bronckos que significa vías respiratorias y ectasia significa ensanchamiento. Es una enfermedad pulmonar crónica que se define como una dilatación anormal e irreversible de los bronquios en la que tanto los tejidos musculares como los elásticos se destruyen debido a una infección a corto y largo plazo. La combinación de estas infecciones provoca daño en uno o ambos pulmones. El sitio de la lesión se diagnostica mediante una tomografía computarizada de alta resolución (TCAR) en la que se muestra que las vías respiratorias más grandes son las más afectadas y que en las vías respiratorias más pequeñas la enfermedad no se explora, por lo que algunos de los pacientes sufren síntomas durante muchos años antes del diagnóstico.

El diagnóstico y el tratamiento de la bronquiectasia ayudan a los pacientes en cuidados críticos a llevar una vida sana, lo que les permite salvar vidas. Esta es la razón por la que aumenta la población de pacientes que padece bronquiectasia y actúa como impulsor del crecimiento del mercado de la bronquiectasia. El alto costo de las herramientas de diagnóstico actúa como un freno para obstaculizar la demanda del mercado de la bronquiectasia. El aumento de los programas de concienciación sobre la bronquiectasia es una de las medidas que han adoptado las organizaciones y las personas de todo el mundo para minimizar la propagación de la bronquiectasia. Estos programas de concienciación pueden actuar como una oportunidad para el crecimiento del mercado de la bronquiectasia. Las complicaciones durante el tratamiento de la bronquiectasia suponen un reto para los proveedores de atención sanitaria, lo que puede suponer un reto para el crecimiento del mercado de la bronquiectasia.

El informe de mercado de bronquiectasias proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado de bronquiectasias, comuníquese con Data Bridge Market Research para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.

Mercado europeo de la bronquiectasiaAlcance y tamaño del mercado de la bronquiectasia

El mercado de la bronquiectasia está segmentado en función del tipo de enfermedad, gravedad, tipo, tipo de fármaco, vía de administración, usuario final y canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y la diferencia en sus mercados objetivo.

  • Según el tipo de enfermedad, el mercado de la bronquiectasia se segmenta en bronquiectasias con fibrosis quística y bronquiectasias sin fibrosis quística. En 2021, se espera que el segmento de bronquiectasias sin fibrosis quística domine el mercado de la bronquiectasia, ya que coexiste con otras afecciones respiratorias, como la enfermedad pulmonar obstructiva crónica (EPOC), y tiene una alta prevalencia entre las mujeres y la población geriátrica.
  • En función de la gravedad, el mercado de la bronquiectasia se segmenta en leve a moderada y moderada a grave. En 2021, se espera que el segmento leve a moderado domine el mercado de la bronquiectasia porque la bronquiectasia es un trastorno respiratorio progresivo y crónico que se caracteriza por tos persistente, vías respiratorias anormalmente dilatadas, producción excesiva de esputo e infecciones pulmonares recurrentes y todos estos síntomas son afecciones graves de por vida.
  • Según el tipo, el mercado de la bronquiectasia se segmenta en diagnóstico y tratamiento. En 2021, se espera que el segmento de tratamiento domine el mercado de la bronquiectasia porque los pacientes diagnosticados con bronquiectasia deben confiar en terapias farmacológicas novedosas y efectivas para llevar una vida normal y saludable.
  • Según el tipo de medicamento, el mercado de la bronquiectasia se segmenta en medicamentos de marca y genéricos. En 2021, se espera que el segmento de marca domine el mercado de la bronquiectasia porque los medicamentos que ofrecen las numerosas empresas son fórmulas patentadas.
  • Según la vía de administración, el mercado de la bronquiectasia se segmenta en oral, parenteral e inhalatoria. En 2021, se espera que el segmento de inhalación domine el mercado de la bronquiectasia porque la vía de administración por inhalación ofrece una administración eficaz del fármaco directamente a las vías respiratorias pulmonares y el creciente avance tecnológico para el lanzamiento de inhaladores inteligentes que permiten a los pacientes mantener una dosis precisa del fármaco también está proporcionando al mercado un crecimiento lucrativo.
  • On the basis of end user, the bronchiectasis market is segmented into hospitals, clinics, home healthcare and others. In 2021, hospitals segment is dominating the bronchiectasis market because hospitals provides with advanced diagnostic tools used for diagnosis of bronchiectasis associated symptoms.
  • On the basis of distribution channel, the bronchiectasis market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. In 2021, hospital pharmacy segment is expected to dominate the bronchiectasis market as hospital pharmacy has wide range of products as per the patients need and demand.

Europe Bronchiectasis Market Country Level Analysis

Europe bronchiectasis market is analyzed and market size information is provided on the basis of the country, disease type, severity, type, drugs type, route of administration, end user and distribution channel as referenced above.

The countries covered in the Europe bronchiectasis market report are the Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe.

Non-CF bronchiectasis segment in Europe region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because non-cystic fibrosis bronchiectasis often coexists with other respiratory conditions such as chronic obstructive pulmonary disease. The prevalence of NCFB is increasing, particularly in women and older individuals. Germany is leading the growth of the Europe bronchiectasis market and non-CF bronchiectasis segment is dominating in the region due to rise in prevalence of respiratory diseases. France is the fastest growing country in the Europe region due to rising research and development. The U.K. holds the third largest market share in the European region because of rising government initiatives to create awareness related to the serious respiratory diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Diagnostic Rate and Increasing Healthcare Expenditure are boosting the Bronchiectasis Market Growth

El mercado de la bronquiectasia también le ofrece un análisis detallado del mercado de cada país, el crecimiento de la industria de la bronquiectasia con las ventas de medicamentos para la bronquiectasia, el impacto de los avances en la tecnología de la bronquiectasia y los cambios en los escenarios regulatorios con su apoyo al mercado de la bronquiectasia. Los datos están disponibles para el período histórico de 2011 a 2019.

Análisis del panorama competitivo y de la cuota de mercado de la bronquiectasia

El panorama competitivo del mercado de la bronquiectasia proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, los sitios e instalaciones de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, las líneas de prueba de productos, las aprobaciones de productos, las patentes, la amplitud y la extensión de los productos, el dominio de las aplicaciones y la curva de la línea de vida de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de la empresa relacionado con el mercado de la bronquiectasia.

Las principales empresas cubiertas en el informe del mercado de bronquiectasias en Europa son Abbott, HERSILL, Indogen, Inc., Boehringer Ingelheim International GmbH, Medline Industries, Inc., Ache Laboratories Farmaceuticos SA, Horizon Therapeutics plc, Janssen Pharmaceuticals, Inc. (una subsidiaria de Johnson & Johnson Services, Inc.), Trudell Medical International, GlaxoSmithKline plc, AstraZeneca, Pfizer Inc., Merck Sharp & Dohme Corp. (una subsidiaria de Merck & Co., Inc.), Novartis AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Dr. Reddy's Laboratories Ltd., Sunovion Pharmaceuticals Inc. (una subsidiaria de Sumitomo Dainippon Pharma Co., Ltd.), Viatris Inc., Covis Pharma, Cipla Inc. entre otros actores nacionales. Los analistas de DBMR comprenden las fortalezas competitivas y brindan un análisis competitivo para cada competidor por separado.

Numerosos lanzamientos de productos y acuerdos son también iniciados por empresas de todo el mundo que también están acelerando el mercado de la bronquiectasia.

Por ejemplo,

  • En junio de 2019, AstraZeneca recibió la aprobación para Breztri Aerosphere (PT010) en Japón para el tratamiento de la EPOC. Breztri Aerosphere contiene budesonida/glicopirronio/fumarato de formoterol y demostró ser una nueva opción de tratamiento entre las personas que sufren inflamación pulmonar y otras enfermedades obstructivas crónicas. Esta aprobación ayudó a la empresa a obtener ventas constantes al expandir las ventas de su producto en varias regiones del mundo.

La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en el mercado de la bronquiectasia, lo que también proporciona el beneficio para que la organización mejore su oferta para la bronquiectasia.

SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Sample Image Click on image to enlarge
  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE bronchiectasis MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. disease type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET drugs type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Pipeline analysis
  5. Europe Bronchiectasis Market: Laws and regulations
  6. Epidemiology
  7. Market Overview
    1. Drivers
      1. Rising Patient Population Suffering from bronchiectasis
      2. growing geriatric population
      3. rising number of smokers and consumption of alcohol
      4. technological advancement for disease testing
      5. growing DIAGNOSTIC rate
    2. restrainTs
      1. high cost of diagnostic tools
      2. product recalls
      3. inappropriate reimbursement policies
    3. opportunities
      1. Rising awareness for prevention of bronchiectasis in primary and secondary care
      2. increasing healthcare expenditure
      3. increase in research regarding the bronchiectasis disease
      4. availability of generic drugs in underdeveloped and developing countries
    4. challenges
      1. complications in the treatment of bronchiectasis
      2. lack of skilled professionals
      3. diagnositic challenges
  8. IMPACT OF COVID-19
    1. PRICE IMPACT
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  9. europe bronchiectasis MARKET, BY disease type
    1. overview
    2. Non-CF Bronchiectasis
    3. CF Bronchiectasis
  10. europe bronchiectasis MARKET, BY severity
    1. overview
    2. mild to moderate
    3. moderate to severe
  11. europe bronchiectasis MARKET, BY type
    1. overview
    2. treatment
      1. Antibiotics
        1. MACROLIDE
          1. AZITHROMYCIN
          2. CLARITHROMYCIN
          3. OTHERS
        2. AMOXICILLIN
        3. CEPHALOSPORIN
          1. SECOND-GENERATION CEPHALOSPORIN
          2. THIRD-GENERATION CEPHALOSPORIN
        4. AMINOGLYCOSIDE
          1. GENTAMICIN
          2. TOBRAMYCIN
        5. FLUOROQUINOLONE
        6. TETRACYCLINS
        7. TRIMETHOPRIM-SULFAMETHOXAZOLE
        8. COMBINATION THERAPY
      2. Corticosteroids
        1. BUDESONIDE
        2. FLUTICASONE
        3. MOMETASONE
        4. FLUNISOLIDE
        5. OTHERS
      3. Bronchodilators
        1. LONG-ACTING BRONCHODILATORS
          1. FORMOTEROL
          2. TIOTROPIUM
          3. SALMETEROL
          4. OTHERS
        2. SHORT-ACTING BRONCHODILATORS
          1. ALBUTEROL
          2. LEVALBUTEROL
          3. OTHERS
      4. Mucus Thinning Medicine
        1. CARBOCISTEINE
        2. BROMHEXINE
        3. OTHERS
      5. Airway Clearance Devices
        1. OSCILLATING POSITIVE EXPIRATORY PRESSURE (PEP)
        2. INTRAPULMONARY PERCUSSIVE VENTILATION (IPV)
        3. POSTURAL DRAINAGE
        4. OTHERS
      6. Oxygen Therapy
        1. OXYGEN CONCENTRATORS
        2. COMPRESSED GAS OXYGEN
        3. LIQUID OXYGEN
      7. Surgery
        1. BRONCHOSCOPY
        2. LUNG TRANSPLANT
      8. Others
    3. diagnosis
      1. Chest CT Scan
      2. Sputum Test
      3. Pulmonary Function Test
      4. X-Ray
      5. Others
  12. europe bronchiectasis MARKET, BY drugs type
    1. overview
    2. branded
    3. generics
  13. europe bronchiectasis MARKET, BY route of administration
    1. overview
    2. inhalation
    3. oral
      1. Tablets
      2. Capsules
      3. Others
    4. parenteral
      1. Intravenous
      2. Subcutaneous
      3. Others
  14. europe bronchiectasis MARKET, BY end user
    1. overview
    2. hospitals
    3. clinics
    4. home healthcare
    5. others
  15. europe bronchiectasis MARKET, BY distribution channel
    1. overview
    2. Hospital Pharmacy
    3. retail Pharmacy
    4. online pharmacy
    5. others
  16. Europe Bronchiectasis Market by geography
    1. Overview
    2. EUROPE
      1. germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. NETHERLANDS
      7. Russia
      8. Switzerland
      9. Belgium
      10. Turkey
      11. Austria
      12. Norway
      13. Hungary
      14. Lithuania
      15. Ireland
      16. Poland
      17. Rest of Europe
  17. Europe Bronchiectasis Market: COMPANY landscape
    1. company share analysis: europe
  18. SWOT
  19. Company profiles
    1. AstraZeneca
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. GlaxoSmithKline plc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Teva Pharmaceutical USA Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Merck Sharp & Dohme Corp. (A subsidiary of Merck & Co., Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Novartis AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. Ache Laboratories Farmaceuticos S.A.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Bayer AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. boehringer ingelheim international gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    10. Cipla Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Covis Pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    12. Dr. Reddy’s Laboratories Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. Electromed, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. hersill
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. home oxygen company
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. horizon therapeutics plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    17. inogen, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    19. medline industries, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. Pfizer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    21. Sunovion Pharmaceuticals Inc. (A Subsidiary of Sumitomo Dainippon Pharma Co., Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    22. Sun Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    23. truedell medical international
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    24. Viatris Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    25. Zydus Pharmaceuticals, Inc. (A subsidiary of Zydus Cadila)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  20. questionnaire
  21. related reports

Lista de Tablas

TABLE 1 Europe bronchiectasis Market, pipeline analysis

TABLE 2 REGULATION imposed by several regulatory agencies in different regions

TABLE 3 Healthcare expenditure in asia-pacific

TABLE 4 THE PRICE OF X-RAY MACHINE

TABLE 5 Europe Bronchiectasis Market, By Disease Type, 2019-2028 (USD Million)

TABLE 6 Europe Non-CF Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 7 Europe CF Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 8 Europe Bronchiectasis Market, By Severity, 2019-2028 (USD Million)

TABLE 9 Europe Mild to Moderate Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 10 Europe Moderate to Severe Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 11 Europe Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 12 europe treatment in bronchiectasis Market, By Region, 2017-2028 (USD Million)

TABLE 13 Europe Treatment in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 14 Europe Treatment by Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 15 Europe Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 16 Europe Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 17 Europe Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 18 Europe Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 19 Europe Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 20 Europe Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 21 Europe Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 22 Europe Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 23 Europe Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 24 Europe Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 25 Europe Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 26 europe diagnosis in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 28 Europe Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 29 europe branded in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 30 europe generics in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 31 Europe Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 32 Europe Inhalation in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 33 Europe Oral in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 34 Europe Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 35 Europe Parenteral in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 36 Europe Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 37 Europe Bronchiectasis Market, By End User, 2019-2028 (USD Million)

TABLE 38 europe hospitals in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 39 europe clinics in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 40 europe home healthcare in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 41 europe others in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 42 Europe Bronchiectasis Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 43 Europe Hospital Pharmacy in Bronchiectasis Market, region, 2019-2028 (USD Million)

TABLE 44 Europe Retail Pharmacy in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 45 Europe Online Pharmacy in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 46 Europe Others in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 47 EUROPE BRONCHIECTASIS MARKET, BY REGION , 2021-2028 (USD MILLION)

TABLE 48 EUROPE BRONCHIECTASIS MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 49 Europe BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 50 Europe BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 51 Europe BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 52 Europe treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 53 Europe treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 54 Europe Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 55 Europe Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 56 Europe Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 57 Europe Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 58 Europe Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 59 Europe Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 60 Europe Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 61 Europe Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 62 Europe Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 63 Europe Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 64 Europe Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 65 Europe Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 66 Europe Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 67 Europe Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 68 Europe Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 69 Europe Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 70 Europe BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 71 Europe BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 72 GERMANY BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 73 GERMANY BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 74 GERMANY BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 75 GERMANY treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 76 GERMANY treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 77 GermanyTreatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 78 GERMANY Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 79 Germany Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 80 Germany Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 81 Germany Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 82 Germany Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 83 Germany Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 84 Germany Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 85 Germany Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 86 Germany Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 87 Germany Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 88 Germany Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 89 Germany Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 90 Germany Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 91 Germany Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 92 Germany Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 93 Germany BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 94 Germany BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 95 France BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 96 France BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 97 France BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 98 France treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 99 France treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 100 France Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 101 France Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 102 France Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 103 France Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 104 France Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 105 France Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 106 France Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 107 France Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 108 France Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 109 France Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 110 France Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 111 France Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 112 France Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 113 France Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 114 France Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 115 France Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 116 France BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 117 France BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 118 U.K. BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 119 U.K. BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 120 U.K. BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 121 U.K. treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 122 U.K. treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 123 U.K. Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 124 U.K. Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 125 U.K. Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 126 U.K. Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 127 U.K. Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 128 U.K. Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 129 U.K. Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 130 U.K. Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 131 U.K. Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 132 U.K. Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 133 U.K. Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 134 U.K. Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 135 U.K. Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 136 U.K. Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 137 U.K. Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 138 U.K. Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 139 U.K. BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 140 U.K. BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 141 Italy BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 142 Italy BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 143 Italy BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 144 Italy treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 145 Italy treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 146 Italy Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 147 Italy Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 148 Italy Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 149 Italy Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 150 Italy Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 151 Italy Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 152 Italy Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 153 Italy Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 154 Italy Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 155 Italy Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 156 Italy Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 157 Italy Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 158 Italy Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 159 Italy Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 160 Italy Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 161 Italy Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 162 Italy BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 163 Italy BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 164 Spain BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 165 Spain BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 166 Spain BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 167 Spain treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 168 Spain treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 169 Spain Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 170 Spain Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 171 Spain Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 172 Spain Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 173 Spain Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 174 Spain Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 175 Spain Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 176 Spain Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 177 Spain Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 178 Spain Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 179 Spain Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 180 Spain Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 181 Spain Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 182 Spain Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 183 Spain Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 184 Spain Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 185 Spain BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 186 Spain BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 187 Netherlands BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 188 Netherlands BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 189 Netherlands BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 190 Netherlands treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 191 Netherlands treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 192 Netherlands Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 193 Netherlands Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 194 Netherlands Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 195 Netherlands Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 196 Netherlands Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 197 Netherlands Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 198 Netherlands Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 199 Netherlands Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 200 Netherlands Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 201 Netherlands Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 202 Netherlands Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 203 Netherlands Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 204 Netherlands Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 205 Netherlands Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 206 Netherlands Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 207 Netherlands Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 208 Netherlands BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 209 Netherlands BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 210 Russia BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 211 Russia BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 212 Russia BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 213 Russia treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 214 Russia treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 215 Russia Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 216 Russia Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 217 Russia Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 218 Russia Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 219 Russia Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 220 Russia Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 221 Russia Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 222 Russia Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 223 Russia Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 224 Russia Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 225 Russia Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 226 Russia Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 227 Russia Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 228 Russia Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 229 Russia Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 230 Russia Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 231 Russia BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 232 Russia BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 233 Switzerland BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 234 Switzerland BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 235 Switzerland BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 236 Switzerland treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 237 Switzerland treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 238 Switzerland Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 239 Switzerland Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 240 Switzerland Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 241 Switzerland Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 242 Switzerland Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 243 Switzerland Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 244 Switzerland Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 245 Switzerland Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 246 Switzerland Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 247 Switzerland Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 248 Switzerland Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 249 Switzerland Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 250 Switzerland Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 251 Switzerland Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 252 Switzerland Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 253 Switzerland Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 254 Switzerland BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 255 Switzerland BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 256 Belgium BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 257 Belgium BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 258 Belgium BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 259 Belgium treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 260 Belgium treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 261 Belgium Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 262 Belgium Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 263 Belgium Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 264 Belgium Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 265 Belgium Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 266 Belgium Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 267 Belgium Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 268 Belgium Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 269 Belgium Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 270 Belgium Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 271 Belgium Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 272 Belgium Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 273 Belgium Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 274 Belgium Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 275 Belgium Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 276 Belgium Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 277 Belgium BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 278 Belgium BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 279 Turkey BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 280 Turkey BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 281 Turkey BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 282 Turkey treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 283 Turkey treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 284 Turkey Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 285 Turkey Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 286 Turkey Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 287 Turkey Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 288 Turkey Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 289 Turkey Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 290 Turkey Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 291 Turkey Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 292 Turkey Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 293 Turkey Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 294 Turkey Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 295 Turkey Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 296 Turkey Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 297 Turkey Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 298 Turkey Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 299 Turkey Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 300 Turkey BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 301 Turkey BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 302 Austria BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 303 Austria BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 304 Austria BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 305 Austria treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 306 Austria treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 307 Austria Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 308 Austria Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 309 Austria Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 310 Austria Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 311 Austria Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 312 Austria Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 313 Austria Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 314 Austria Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 315 Austria Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 316 Austria Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 317 Austria Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 318 Austria Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 319 Austria Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 320 Austria Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 321 Austria Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 322 Austria Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 323 Austria BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 324 Austria BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 325 Norway BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 326 Norway BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 327 Norway BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 328 Norway treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 329 Norway treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 330 Norway Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 331 Norway Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 332 Norway Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 333 Norway Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 334 Norway Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 335 Norway Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 336 Norway Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 337 Norway Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 338 Norway Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 339 Norway Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 340 Norway Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 341 Norway Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 342 Norway Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 343 Norway Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 344 Norway Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 345 Norway Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 346 Norway BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 347 Norway BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 348 Hungary BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 349 Hungary BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 350 Hungary BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 351 Hungary treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 352 Hungary treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 353 Hungary Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 354 Hungary Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 355 Hungary Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 356 Hungary Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 357 Hungary Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 358 Hungary Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 359 Hungary Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 360 Hungary Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 361 Hungary Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 362 Hungary Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 363 Hungary Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 364 Hungary Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 365 Hungary Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 366 Hungary Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 367 Hungary Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 368 Hungary Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 369 Hungary BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 370 Hungary BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 371 Lithuania BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 372 Lithuania BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 373 Lithuania BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 374 Lithuania treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 375 Lithuania treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 376 Lithuania Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 377 Lithuania Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 378 Lithuania Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 379 Lithuania Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 380 Lithuania Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 381 Lithuania Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 382 Lithuania Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 383 Lithuania Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 384 Lithuania Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 385 Lithuania Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 386 Lithuania Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 387 Lithuania Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 388 Lithuania Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 389 Lithuania Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 390 Lithuania Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 391 Lithuania Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 392 Lithuania BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 393 Lithuania BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 394 Ireland BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 395 Ireland BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 396 Ireland BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 397 Ireland treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 398 Ireland treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 399 Ireland Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 400 Ireland Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 401 Ireland Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 402 Ireland Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 403 Ireland Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 404 Ireland Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 405 Ireland Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 406 Ireland Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 407 Ireland Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 408 Ireland Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 409 Ireland Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 410 Ireland Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 411 Ireland Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 412 Ireland Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 413 Ireland Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 414 Ireland Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 415 Ireland BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 416 Ireland BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 417 Poland BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 418 Poland BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 419 Poland BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 420 Poland treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 421 Poland treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 422 Poland Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 423 Poland Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 424 Poland Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 425 Poland Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 426 Poland Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 427 Poland Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 428 Poland Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 429 Poland Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 430 Poland Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 431 Poland Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 432 Poland Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 433 Poland Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 434 Poland Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 435 Poland Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 436 Poland Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 437 Poland Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 438 Poland BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 439 Poland BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 440 rest of Europe BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

Lista de figuras

FIGURE 1 Europe BRONCHIECTASIS MARKET: SEGMENTATION

FIGURE 2 EUROPE BRONCHIECTASIS MARKET : DATA TRIANGULATION

FIGURE 3 europe Bronchiectasis Market: DROC ANALYSIS

FIGURE 4 Europe Bronchiectasis market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Bronchiectasis Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Bronchiectasis MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Bronchiectasis MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE BRONCHIECTASIS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE BRONCHIECTASIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE bronchiectasis MARKET: MARKET drugs type COVERAGE GRID

FIGURE 11 Europe Bronchiectasis market: SEGMENTATION

FIGURE 12 RISING PATIENT POPULATION SUFFERING FROM BRONCHIECTASIS is DRIVing THE europe Bronchiectasis MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 NON-CF BRONCHIECTASIS SEGMENT is expected to account for the largest share of the europe BRONCHIECTASIS MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE Bronchiectasis market

FIGURE 15 Number of Persons Aged 60 Years Across Several Regions in 2017 and 2050

FIGURE 16 prevalence of bronchiectasis by age in korea population (2019)

FIGURE 17 Health Spending by Major Sources of Funds

FIGURE 18 europe bronchiectasis market: BY disease type, 2021

FIGURE 19 europe bronchiectasis market: BY disease type, 2019-2028 (USD Million)

FIGURE 20 europe bronchiectasis market: BY disease type, CAGR (2021-2028)

FIGURE 21 europe bronchiectasis market: BY disease type, LIFELINE CURVE

FIGURE 22 europe bronchiectasis market: BY severity, 2021

FIGURE 23 europe bronchiectasis market: BY severity, 2019-2028 (USD Million)

FIGURE 24 europe bronchiectasis market: BY severity, CAGR(2021-2028)

FIGURE 25 europe bronchiectasis market: BY severity, LIFELINE CURVE

FIGURE 26 europe bronchiectasis market: BY type, 2021

FIGURE 27 europe bronchiectasis market: BY type, 2019-2028 (USD Million)

FIGURE 28 europe bronchiectasis market: BY type, CAGR (2021-2028)

FIGURE 29 europe bronchiectasis market: BY type, LIFELINE CURVE

FIGURE 30 europe bronchiectasis market: BY drugs type, 2021

FIGURE 31 europe bronchiectasis market: BY drugs type, 2019-2028 (USD Million)

FIGURE 32 europe bronchiectasis market: BY drugs type, CAGR (2021-2028)

FIGURE 33 europe bronchiectasis market: BY drugs type, LIFELINE CURVE

FIGURE 34 europe bronchiectasis market: BY route of administration, 2021

FIGURE 35 europe bronchiectasis market: BY route of administration, 2019-2028 (USD Million)

FIGURE 36 europe bronchiectasis market: BY route of administration, CAGR (2021-2028)

FIGURE 37 europe bronchiectasis market: BY route of administration, LIFELINE CURVE

FIGURE 38 europe bronchiectasis market: BY end user, 2021

FIGURE 39 europe bronchiectasis market: BY end user, 2019-2028 (USD Million)

FIGURE 40 europe bronchiectasis market: BY end user, CAGR (2021-2028)

FIGURE 41 europe bronchiectasis market: BY end user, LIFELINE CURVE

FIGURE 42 europe bronchiectasis market: BY distribution channel, 2021

FIGURE 43 europe bronchiectasis market: BY distribution channel, 2019-2028 (USD Million)

FIGURE 44 europe bronchiectasis market: BY distribution channel, CAGR (2021-2028)

FIGURE 45 europe bronchiectasis market: BY distribution channel, LIFELINE CURVE

FIGURE 46 EUROPE BRONCHIECTASIS market: SNAPSHOT (2020)

FIGURE 47 EUROPE BRONCHIECTASIS market: BY COUNTRY (2020)

FIGURE 48 EUROPE BRONCHIECTASIS market: BY COUNTRY (2021 & 2028)

FIGURE 49 EUROPE BRONCHIECTASIS market: BY COUNTRY (2020 & 2028)

FIGURE 50 EUROPE BRONCHIECTASIS market: BY Disease type (2021-2028)

FIGURE 51 Europe BRONCHIECTASIS market: SNAPSHOT (2020)

FIGURE 52 Europe BRONCHIECTASIS market: BY COUNTRY (2020)

FIGURE 53 Europe BRONCHIECTASIS market: BY COUNTRY (2021 & 2028)

FIGURE 54 Europe BRONCHIECTASIS market: BY COUNTRY (2020 & 2028)

FIGURE 55 Europe BRONCHIECTASIS market: BY Disease type (2021-2028)

FIGURE 56 Europe Bronchiectasis market: company share 2020 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Explorar páginas relacionadas

Banner